Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03021707 · ClinicalTrials.gov registry record · NA
Early Feasibility Study of UV-Femtosecond Laser Assisted Lenticular Extraction
A NA study of Refractive Error - Myopia Severe and Refractive Error - Myopia Simple, sponsored by Alcon Research.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
- 4
- Study locations
NCT03021707: Completed NA study of Refractive Error - Myopia Severe and Refractive Error - Myopia Simple, sponsored by Alcon Research.
NCT03021707 is a NA study of Refractive Error - Myopia Severe and Refractive Error - Myopia Simple that has completed, run by Alcon Research. The registered enrollment target is 7 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). The trial reports 4 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03021707, a NA study of Refractive Error - Myopia Severe and Refractive Error - Myopia Simple, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
- 4
- Study locations
Study Summary
The purpose of this study is to evaluate the initial safety of the UV-FS laser in humans.
Primary Outcome
Corneal haze will be assessed on a scale of 0 to 4, where 0 = clear or no haze can be seen, and 4 = opacity is visible without slit lamp, greatly obscures iris detail.
Conditions Studied
Interventions
- DEVICE WaveLight® Ultraviolet Femtosecond (FS) Laser System
- PROCEDURE Laser Assisted Lenticular Extraction
Study Locations (4)
Other
- Alcon Investigative Site - Dublin
- Alcon Investigative Site - Singapore
South Dakota
- Alcon Investigative Site - Sioux Falls
Texas
- Alcon Investigative Site - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2017-03-07 |
| Est. Completion | 2019-10-17 |
| Phase | NA |
What the finished NCT03021707 record still lists
NCT03021707 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 2 conditions, with Refractive Error - Myopia Severe appearing as the primary indexed condition, and to 2 interventions - of which WaveLight® Ultraviolet Femtosecond (FS) Laser System is the first listed.
NCT03021707 reports a single indexed study location in Other, South Dakota, Texas.
Frequently Asked Questions
What is clinical trial NCT03021707 about?
NCT03021707 is a clinical study titled "Early Feasibility Study of UV-Femtosecond Laser Assisted Lenticular Extraction". The purpose of this study is to evaluate the initial safety of the UV-FS laser in humans.
What is the current status of trial NCT03021707?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2017-03-07. Estimated completion is 2019-10-17.
What conditions does trial NCT03021707 study?
This clinical trial studies the following conditions: Refractive Error - Myopia Severe, Refractive Error - Myopia Simple.
What interventions are being tested in trial NCT03021707?
The interventions under investigation include: WaveLight® Ultraviolet Femtosecond (FS) Laser System (DEVICE), Laser Assisted Lenticular Extraction (PROCEDURE).
Who is sponsoring clinical trial NCT03021707?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03021707 being conducted?
This trial has 4 study locations across South Dakota, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03021707's enrollment target sits among peer trials
7 1982nd of 2000 higher than 18 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI